Related Experiment Videos
The first infant to survive a generalized BCG infection
Acta Paediatrica Scandinavica
|January 1, 1982
Summary
A young boy survived a severe generalized BCG infection after 2 years of treatment with streptomycin, isoniazid, and rifampicin. This case highlights a rare survival from disseminated BCG disease in a child.
Area of Science:
- Pediatrics
- Infectious Diseases
- Immunology
Background:
- Disseminated Bacillus Calmette-Guérin (BCG) infection is a rare but serious complication, particularly in immunocompromised individuals.
- Treatment typically involves prolonged antimicrobial therapy, but outcomes in severe generalized cases remain challenging.
- Understanding the immunological response in survivors is crucial for managing such infections.
Observation:
- A 17-month-old boy developed severe generalized BCG infection.
- He received a 2-year course of streptomycin, isoniazid, and rifampicin.
- The patient exhibited a persistent discrepancy between humoral and cellular tuberculin purified protein derivative (PPD) reactivity despite normal conventional immunological assessments.
Findings:
- The child achieved apparent cure by age 5 years.
- This represents the first reported case of a child surviving generalized BCG infection.
- Normal immunological parameters suggest intact, albeit potentially atypical, immune responses in this survivor.
Implications:
- This case demonstrates the possibility of recovery from severe disseminated BCG infection with appropriate antimicrobial treatment.
- Further research into the specific immunological mechanisms enabling survival in such cases is warranted.
- This finding may inform treatment strategies and prognostic assessments for pediatric BCG infections.